People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

21 Nov 2014
Price Change (% chg)

CHF0.45 (+0.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Datar, Srikant 

Brief Biography

Dr. Srikant Datar, Ph.D., has been Member of the Board of Directors of Novartis AG since 2003. He qualifies as Independent Non-Executive Director. He is Chairman of the Audit and Compliance Committee and Member of the Risk Committee and the Compensation Committee at the Company. Dr. Datar has worked as an accountant and planner in industry, and as a professor at Carnegie Mellon University, Stanford University and Harvard University in the United States. His research interests are in the areas of cost management, measurement of productivity, product development, timebased competition, incentives and performance evaluation. He is the author of a number of scientific publications and has received several academic awards and honors. Dr. Datar has advised and worked with numerous companies in research, development and training. Dr. Datar is Arthur Lowes Dickinson Professor at the Graduate School of Business Administration at Harvard University. He is also Member of the Board of Directors of ICF International Inc. and of Stryker Corp., both in the United States, and of KPIT Cummins Infosystems Ltd., India. He graduated with distinction in mathematics and economics from the University of Bombay, India, in 1973. He is a Chartered Accountant and holds two masters degrees and a Doctor of Philosophy (Ph.D.) from Stanford University, United States.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
360,000 -- 360,051 720,051

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt


Joseph Jimenez


Ulrich Lehner


Harry Kirsch


Peter Kornicker


Felix Ehrat

As Of 30 Dec 2012
Search Stocks